While it has previously been shown that TP53 is dysregulated in CLL cells,27 to the best of our knowledge, we are the first to compare basal protein levels of TP53 between CLL and healthy donor CD19+ cells. This evidence concerns the gene CD19 and B-cell chronic lymphocytic leukemia.